Post job

Apollo Endosurgery's revenue is $76.9 million.

What is Apollo Endosurgery's revenue?

Apollo Endosurgery's annual revenue is $76.9M. Zippia's data science team found the following key financial metrics about Apollo Endosurgery after extensive research and analysis.
  • Apollo Endosurgery has 215 employees, and the revenue per employee ratio is $357,469.
  • Apollo Endosurgery's peak quarterly revenue was $1.1B in 2014(q3).
  • Apollo Endosurgery peak revenue was $76.9M in 2022.
  • Apollo Endosurgery annual revenue for 2021 was 63.0M, 49.8% growth from 2020.
  • Apollo Endosurgery's revenue growth from 2007 to 2022 is 20,540.91%.
  • Apollo Endosurgery annual revenue for 2022 was 76.9M, 22.01% growth from 2021.

On this page

Most recent quarter revenue
$21.3M (Q4'2022)
Company most recent quarter revenue
Peak revenue
$76.9M (2022)
Company peak revenue
Revenue / employee
$357,470
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Most recent quarter revenue
$21.3M (Q4'2022)
Company most recent quarter revenue
Peak revenue
$76.9M (2022)
Company peak revenue
Revenue / employee
$357,470
Company revenue / employee

Apollo Endosurgery historical revenue

Apollo Endosurgery's peak revenue was $76.9M in 2022. The peak quarterly revenue was $1.1B in 2014(q3).

Apollo Endosurgery's revenue increased from $372.3k in 2007 to $76.9M currently. That's a 20,540.91% change in annual revenue.

Apollo Endosurgery annual revenue

$77M
$61M
$46M
$31M
$15M
$0
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022

Apollo Endosurgery annual revenue over time

Fiscal year / yearApollo Endosurgery revenue
2009$11.9M
2010$7.8M
2011$9.4M
2012$6.7M
2013$8.0M
2014$5.1M
2015$67.8M
2016$64.7M
2017$64.3M
2018$60.9M
2019$50.7M
2020$42.0M
2021$63.0M
2022$76.9M

How accurately did Apollo Endosurgery's revenue projections match actual performance?

Zippia waving zebra

Apollo Endosurgery annual growth

Apollo Endosurgery saw the greatest revenue growth in 2015, when revenue increased by 1,234.33%.

Apollo Endosurgery had the lowest revenue growth in 2014, when revenue changed by -36.39%.

Apollo Endosurgery annual growth rate over time

YearApollo Endosurgery growth
2009
316%
2010
-34%
2011
20%
2012
-29%
2013
19%
2014
-36%
2015
1234%
2016
-5%
2017
-1%
2018
-5%
2019
-17%
2020
-17%
2021
50%
2022
22%

Apollo Endosurgery quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$21M
$17M
$13M
$9M
$4M
$0
2018
2019
2020
2021
2022

Apollo Endosurgery quarterly growth rate over time

YearQ1Q2Q3Q4
2009$2.7M$2.8M$4.9M$1.6M
2010$4.1M$1.0M$769,025$2.0M
2011$2.8M$1.5M$1.8M$3.3M
2012$2.8M$1.3M$1.4M$1.2M
2013$1.1M$2.0M$2.6M$2.3M
2014$1.7M$1.3M$1.1B($4.2B)
2015$783.9M$747.6M$61.3M($1.5B)
2016$16.3M$17.3M$15.8M$15.3M
2017$14.5M$17.1M$16.5M$16.1M
2018$15.7M$15.8M$14.1M$15.2M
2019$13.2M$14.3M$11.3M$12.0M
2020$10.7M$5.6M$12.8M$12.9M
2021$13.9M$16.6M$16.4M$16.2M
2022$16.7M$19.3M$19.6M$21.3M

Apollo Endosurgery jobs nearby

Do you work at Apollo Endosurgery?

Is Apollo Endosurgery transparent about its revenue structure?

Apollo Endosurgery financial information

CEOTodd Newton
Company TypePublic
Employees Number215
Date Founded2006
HeadquartersAustin, Texas
Number of Locations1
Revenue$76.9M
Net Income-$39,839,000
Gross Proft$42.4M (2022)
EBITDA($32.8M) (2022)
PE Ratio-2.45
Tax Rate-0.0%
Market Capitalization$97.6M
Total Assets$110,231,000
TickerAPEN

Apollo Endosurgery jobs you might like

Apollo Endosurgery financing

Apollo Endosurgery received early financing of $11.5M on 2007-10-08.

SeriesRound sizeDate
Series A$11.5M10/2007
Debt Financing$3M03/2009
Series B$47.6M02/2012
Series Unknown$5M07/2013
Debt Financing$50M12/2013
Private Equity$40M12/2013
Series C$60.7M08/2014
Debt Financing$50M03/2015
Convertible Note$22M11/2015
Post Ipo Equity$23.7M06/2018
Post Ipo Debt$20M08/2019
Post Ipo Equity$65M10/2021
Post Ipo Debt$35M12/2021

Apollo Endosurgery investors

InvestorsSecurity type
H.I.G. Capital Inc.Series A
PTV Healthcare CapitalSeries A
Novo Holdings ASeries B
CPMGSeries B
H.I.G. Capital Inc.Series B
Remeditex Ventures LLCSeries B
PTV Healthcare CapitalSeries B
Oxford Finance LLCDebt Financing
MidCap FinancialDebt Financing
EAST WEST BANCORP INCDebt Financing
UT Horizon FundSeries C
Athyrium Capital Management LPDebt Financing
PTV Healthcare CapitalConvertible Note
Craig Hallum Capital GroupPost Ipo Debt
Innovatus Capital Partners LLCPost Ipo Debt

Apollo Endosurgery competitors

Company nameAverage salaryRevenueEmployee sizeJob openings
Medical Device Company$81,284---
PerkinElmer$85,448$2.8B14,000116
Spacelabs Healthcare$96,851$1.5B1,043-
Solta$75,901$144.5M200-
Medtronic Spine LLC$50,369$11.0M50-
Stereotaxis$84,539$28.1M1303
Defibtech$69,064$23.0M1322
Spinewave$52,057$6.1M100-
MAKO Surgical$90,432$102.7M436-
RQM$73,114$15.4M4055

Apollo Endosurgery revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Apollo Endosurgery, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Apollo Endosurgery. The employee data is based on information from people who have self-reported their past or current employments at Apollo Endosurgery. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Apollo Endosurgery. The data presented on this page does not represent the view of Apollo Endosurgery and its employees or that of Zippia.

Apollo Endosurgery may also be known as or be related to APOLLO ENDOSURGERY INC., Apollo Endosurgery, Apollo Endosurgery Inc, Apollo Endosurgery, Inc. and Apollo Endosurgery, Inc. (Inactive).